Navigation Links
NJIT professor receives Fulbright to study at University of Salerno
Date:7/28/2010

Anthony D. Rosato, PhD, a professor in the department of mechanical and industrial engineering at NJIT http://www.njit.edu/ has received a Fulbright Senior Research Award to study the dynamic behavior of systems composed of particles at the University of Salerno, in Fisciano, Italy. He'll start the four-month program next May.

Rosato recently presented an invited seminar there entitled "Microstructure Evolution in Tapped Monodisperse Spheres via Discrete Element Modeling." This Fulbright scholarship will be one of only four awarded this year to scholars like him studying in Italy. Rosato, who will live near the university about an hour south of Naples, said what attracted him was the chance of collaboration with someone whose research is similar to his own.

People don't realize it, but almost everything they touch or use is can be broken into a granular or particulate form. "The food we eat, pharmaceutical we take, chemicals, materials, glass, plasticsare all granular in nature," he said.

His quest is to understand how granular materials move and the mechanics by which their density changes when tapped or bumped. "Say you buy detergent or cereal. Inevitably you get them home, open the box and a portion of the content seems to have disappeared," he said. "Sure the item was sold by weight, not volume. But why in the process of being shipped and handled, does the volume fall? It sounds simple. But, in fact, this is a very complicated problem."

In 1999, Rosato http://www.njit.edu/news/experts/rosato.php founded at NJIT the Granular Science Laboratory (GSL) to conduct basic research aimed at describing and predicting the behavior of systems comprised of solids and fluids. The laboratory also aims to educate undergraduate and graduate students by providing research opportunities.

Students who work in the laboratory a
'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Rensselaer professor uncovers mysterious workings of cholera bacteria
2. University of Washington professors lifetime efforts receive international recognition
3. Top professor will report new way to discover drugs that aid regenerative medicine
4. Professor discovers way to slow the growth of malignant melanoma
5. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
6. LSU professor uses volcanic emissions to study Earths atmospheric past
7. IU professors new textbook uses the best science writing from the New York Times
8. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
9. IEEE touts NJIT professor for expertise in underwater acoustic communication
10. University of Delaware professor wins Powe Award from Oak Ridge Associated Universities
11. K-State professor using NSF award to study the impact of nitrogen deposition on global change
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NJIT professor receives Fulbright to study at University of Salerno
(Date:10/15/2014)... , Oct. 15, 2014 Sandata ... for home and community-based care, today announced it ... implementing Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™) ... is a home health company founded in 1996 ... . The study details ...
(Date:10/15/2014)... linked increased resistance to bacterial pneumonia in female mice ... estrogen. , Females are naturally more resistant to respiratory ... has shown that increased resistance to bacterial pneumonia in ... synthase 3 (NOS3). They also show that this enzyme ... sex hormone estrogen. , The team, lead by Professor ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... of light for more than a billion people in developing ... overlooked in greenhouse gas estimates, according to a new study ... the University of Illinois. Results from field and ... kerosene in wick lamps used for light in 250-300 ...
... varieties with higher yields and enhanced nutritional content, researchers ... with scientists at nine other institutions in an attempt ... endeavor, led by researchers at the U.K.-based Biotechnology and ... in the journal Nature . "This work ...
... white blood cells has a surprising second role in protecting ... researchers report. The molecule, microRNA-223, affects how cells respond to ... and thus the cells, likelihood of suffering permanent damage. ... very specific effects in the brain, one that could be ...
Cached Biology News:Study IDs kerosene lamps as big source of black carbon 2UC Davis researchers aid effort to sequence the complex wheat genome 2Double duty: Immune system regulator found to protect brain from effects of stroke 2
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... October 20, 2014 Earle ... LLC, announced today that Ellen Teplitzky, an experienced ... for the pharmaceutical industry, has joined the firm ... its legal services practice. NDA Partners provides ... witness and testimony, to top law firms and ...
(Date:10/19/2014)... October 20, 2014 OCTOBER ... Meeting (ABIM). ABIM will take place ... information about ABIM 2014 is now available ... Delegates representing companies and organizations from all ... obtain information on the latest products and ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The Asian ... in Asian with analysis and forecast of revenue. The ... grow to around $463.9 million by 2018, at a ... Browse through the TOC of the Asian Automatic patient ... analysis provided. This also provides a glimpse of the ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3
... Joshua Hare to Chair the Board LA JOLLA, Calif., ... CDXP) announced today the formation of a Medical Advisory ... program of CDP-1050 for the treatment of heart failure.The ... in the design and oversight of the planned CDP-1050 ...
... /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (OTC ... the,Company,), one of the leading plasma-based ... China (,PRC,), today announced that the ... Products Co.,Ltd. (,Shandong Taibang,) has been ...
... Pain IndicationsLA JOLLA, Calif., Feb. 11 TorreyPines ... announced that oral administration of NGX426, an AMPA/kainate-type ... healthy male and female subjects when dosed once ... this Phase I trial demonstrating the safety and ...
Cached Biology Technology:Cordex Pharma Forms Heart Failure Medical Advisory Board 2Cordex Pharma Forms Heart Failure Medical Advisory Board 3Cordex Pharma Forms Heart Failure Medical Advisory Board 4Cordex Pharma Forms Heart Failure Medical Advisory Board 5China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 2China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 3First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 2First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 3First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 4